MedAssets (MDAS)

MedAssets in an overlooked and unhyped recent IPO that has the synergy to succeed in the on-demand software sector. First, the company is poised to succeed regardless of a recession, economic slowdown, or continued bull market because its technology delivers solutions designed to improve operating margin, cash flow, and expense for hospitals and health systems from 1-10 percent. These factors increase the bottom line. Second, Its Revenue Cycle Management segment has more than 1,000 hospital customers, +125 customer base health systems, +2,500 acute care hospitals, and approximately 30,000 ancillary provider locations. Third, MedAssets 2006 revenue growth rate was 80%, which was nearly double the rate of Athena Health (ATHN) and 5 percent lower than Netsuite (N) two recent IPOs that have skyrocketed. Bottom line, it's not to late to establish a position in MDAS before the underwriters initiate coverage (typically positive) and the investing public catches on to this overlooked and unhyped stock.